UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015733 |
|---|---|
| Receipt number | R000018245 |
| Scientific Title | Safety of cell immunotherapy for refractory malignant tumor using natural killer cell-like effector cells (CA-MED-NK001) selectively amplified from autologous mononuclear cells in peripheral blood |
| Date of disclosure of the study information | 2014/11/21 |
| Last modified on | 2017/05/24 19:24:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/11/21 17:06:31 | ||
| 2 | Update | 2014/11/28 14:29:47 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2014/11/28 14:33:53 | TEL TEL Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 4 | Update | 2014/11/28 14:36:48 | Recruitment status Last follow-up date Date trial data considered complete |
|
| 5 | Update | 2015/10/13 21:11:43 | Target sample size |
|
| 6 | Update | 2015/10/13 21:12:42 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2016/05/21 20:29:00 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 8 | Update | 2016/05/21 20:33:51 | Email Name of primary person or sponsor Organization |
|
| 9 | Update | 2016/05/28 20:49:51 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Institute Department |
|
| 10 | Update | 2017/05/24 19:24:11 | Recruitment status Results Results |
